2m 2m 2m 2m 2m 2m 2m
CAPSOVISION (CV)
NASDAQ
$5.95-$0.07 (-1.25%)
Price as of Aug 24, 2026 1:44 PM EDT- $301.3MMarket Cap
- 50.50%1-Year Change
- Medical DevicesIndustry
CAPSOVISION (CV)
$5.95-$0.07 (-1.25%)
Annual
Quarterly
12/31/2025 | ||
|---|---|---|
Income Statement | ||
Total Operating Revenue | 13.6M N/A | |
Cost of Revenue | 6.4M N/A | |
Gross Profit | 7.2M N/A | |
Sales and Marketing Expense | 7.5M N/A | |
Research and Development Expense | -18.3M N/A | |
Depreciation and Amortization Expense | 216,000 N/A | |
Total Operating Expenses | 32.7M N/A | |
Operating Profit | -25.5M N/A | |
Interest Income | N/A N/A | |
Interest Expense | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | |
Total Nonoperating Income and Expense | 225,000 N/A | |
Income before Taxes | -25.3M N/A | |
Income Taxes | 24,000 N/A | |
Extraordinary Items | N/A N/A | |
Net Income | -25.3M N/A | |
Net Income from Continuing Operations Applicable to Common | -25.3M N/A | |
Basic EPS and Net Income | -1.03 N/A | |
Diluted EPS and Net Income | -1.03 N/A | |
Basic Weighted Average Shares | 24.6M N/A | |
Diluted Weighted Average Shares | 24.6M N/A | |
Balance Sheet | ||
Cash and Cash Equivalents | 10.1M N/A | |
Short-Term Investments | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 10.1M N/A | |
Total Current Assets | 16.7M N/A | |
Accumulated Depreciation | 575,000 N/A | |
Property and Plant and Equipment and Net | 611,000 N/A | |
Total Long-Term Assets | 41,000 N/A | |
Total Assets | 18.2M N/A | |
Income Taxes Payable | 79,000 N/A | |
Total Short-Term Debt | N/A N/A | |
Total Current Liabilities | 4.4M N/A | |
Total Long-Term Debt | N/A N/A | |
Total Long-Term Liabilities | 477,000 N/A | |
Total Liabilities | 4.9M N/A | |
Retained Earnings | -155.7M N/A | |
Total Stockholders Equity | 13.3M N/A | |
Total Shares Outstanding | 46.9M N/A | |
Cash Flow | ||
Cash from Operating Activities | -22.9M N/A | |
Capital Expenditures | 90,000 N/A | |
Cash from Investing Activities | -90,000 N/A | |
Dividends Paid | N/A N/A | |
Cash from Financing Activities | 23.6M N/A | |
Financials Ratio | ||
Gross Margin | N/A N/A | |
Operating Margin | N/A N/A | |
Return on Assets | N/A N/A | |
Return on Equity | N/A N/A | |
Revenue Growth | N/A N/A | |
Current Ratio | N/A N/A | |
Cash Ratio | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow